Citations

Showing 10 of 108135 citations.

Letter: Home-Turf Advantage? The Neurosurgery Residency Match During the COVID-19 Pandemic
Riviere-Cazaux, Cécile , Antezana, Luis A. , Xie, Katherine , Gompel, Jamie J. Van , Xie, Katherine Z , Van Gompel, Jamie J , Antezana, Luis

Mayo Clinic

Neurosurgery | September 8, 2021 | Volume: 89 | Issue: 6 | Pages: E328-E329

10.1093/neuros/nyab369 | PMID 34624087 Get It

Thrombus Histology as It Relates to Mechanical Thrombectomy: A Meta-Analysis and Systematic Review
Bhambri, Ankur, Adapa, Arjun R. , Liu, Yang , Boeckh‐Behrens, Tobias , Procházka, Václav , Hernández‐Fernández, Francisco , Hashimoto, Tetsuya , Chaudhary, Neeraj , Savastano, Luis E., Chaudhary, Neeraj , Pandey, Aditya S , Liu, Yang , Barbella-Aponte, Rosa Angélica , Savastano, Luis , Gemmete, Joseph John , Shih, Albert J.

Mayo Clinic

Neurosurgery | September 8, 2021 | Volume: 89 | Issue: 6 | Pages: 1122-1131

10.1093/neuros/nyab366 | PMID 34634805 Get It

Abstract BACKGROUND Appropriate thrombus-device interaction is critical for recanalization. Histology can serve as a proxy for mechanical properties, and thus inform technique selection. OBJECTIVE To investigate the value of histologic characterization, we conducted a systematic review and meta-analysis on the relationship between thrombus histology and recanalization, technique, etiology, procedural efficiency, and imaging findings. METHODS In this meta-analysis, we identified studies published between March 2010 and March 2020 reporting findings related to the histologic composition of thrombi in large vessel occlusion stroke. Studies with at least 10 patients who underwent mechanical thrombectomy using stent retriever or aspiration were considered. Only studies in which retrieved thrombi were histologically processed were included. Patient-level data were requested when data could not be directly extracted. The primary outcome assessed was the relationship between thrombus histology and angiographic outcome. RESULTS A total of 22 studies encompassing 1623 patients met inclusion criteria. Clots associated with good angiographic outcome had higher red blood cell (RBC) content (mean difference [MD] 9.60%, 95% CI 3.85-15.34, P = .008). Thrombi retrieved by aspiration had less fibrin (MD −11.39, 95% CI −22.50 to −0.27, P = .046) than stent-retrieved thrombi. Fibrin/platelet-rich clots were associated with longer procedure times (MD 13.20, 95% CI 1.30-25.10, P = .037). Hyperdense artery sign was associated with higher RBC content (MD 14.17%, 95% CI 3.07-25.27, P = .027). No relationship was found between composition and etiology. CONCLUSION RBC-rich thrombi were associated with better recanalization outcomes and shorter procedure times, suggesting that preinterventional compositional characterization may yield important prognostic and therapeutic guidance.
Flow Diversion for Middle Cerebral Artery Aneurysms: An International Cohort Study
Diestro, Jose Danilo Bengzon , Adeeb, Nimer , Dibas, Mahmoud , Boisseau, William , Harker, Pablo , Brinjikji, Waleed , Xiang, Sishi, Joyce, Evan, Shapiro, Maksim , Raz, Eytan , Pickett, Gwynedd E. , Alotaibi, Naif M. , Regenhardt, Robert W. , Spears, Julian , Burkhardt, Jan‐Karl , Hafeez, Muhammad Ubaid , Kan, Peter , Nossek, Erez , Zhang, Hongqi , Rinaldo, Lorenzo , Stapleton, Christopher J. , Rabinov, James D. , Patel, Aman B. , Marotta, Thomas R. , Dmytriw, Adam A. , Burkhardt, Jan-Karl , Kan, Peter , Rinaldo, Lorenzo , Lanzino, Giuseppe , Dmytriw, Adam A , Dibas, Mahmoud , Diestro, Jose Danilo B , Harker, Pablo , Regenhardt, Robert W , Hafeez, Muhammad U , Burkhardt, Jan‐Karl , Parra-Fariñas, Carmen , Bernstock, Joshua D. , Griessenauer, Christoph J. , Grandhi, Ramesh , Taussky, Philipp , Hong, Tao , Lanzino, Giuseppe , Roy, Daniel C.

Mayo Clinic

Neurosurgery | September 8, 2021 | Volume: 89 | Issue: 6 | Pages: 1112-1121

10.1093/neuros/nyab365 | PMID 34624100 Get It

Abstract BACKGROUND Open surgery has traditionally been preferred for the management of bifurcation middle cerebral artery (MCA) aneurysms. Flow diverting stents present a novel endovascular strategy for aneurysm treatment. OBJECTIVE To add to the limited literature describing the outcomes and complications in the use of flow diverters for the treatment of these complex aneurysms. METHODS This is a multicenter retrospective review of MCA bifurcation aneurysms undergoing flow diversion. We assessed post-treatment radiological outcomes and both thromboembolic and hemorrhagic complications. RESULTS We reviewed the outcomes of 54 aneurysms treated with flow diversion. Four (7.4%) of the aneurysms had a history of rupture (3 remote and 1 acute). Fourteen (25.9%) of the aneurysms already underwent either open surgery or coiling prior to flow diversion. A total of 36 out of the 45 aneurysms (80%) with available follow-up data had adequate aneurysm occlusion with a median follow-up time of 12 mo. There were no hemorrhagic complications but 16.7% (9/54) had thromboembolic complications. CONCLUSION Flow diverting stents may be a viable option for the endovascular treatment of complex bifurcation MCA aneurysms. However, compared to published series on the open surgical treatment of this subset of aneurysms, flow diversion has inferior outcomes and are associated with a higher rate of complications.
Classifying Patients Operated for Spondylolisthesis: A K-Means Clustering Analysis of Clinical Presentation Phenotypes
Chan, Andrew K. , Wozny, Thomas A. , Bisson, Erica F. , Pennicooke, Brenton , Bydon, Mohamad , Glassman, Steven D. , Foley, Kevin T. , Shaffrey, Christopher I. , Potts, Eric A. , Shaffrey, Mark E., Coric, Domagoj , Knightly, John J. , Park, Paul , Wang, Michael Y. , Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L. , Virk, Michael S. , Kerezoudis, Panagiotis , Alvi, Mohammed Ali , Haid, Regis W., Mummaneni, Praveen V. , Alvi, Mohammed A, Alvi, Mohammed Ali , Guan, Jian

Mayo Clinic

Neurosurgery | September 8, 2021 | Volume: 89 | Issue: 6 | Pages: 1033-1041

10.1093/neuros/nyab355 | PMID 34634113 Get It

Abstract BACKGROUND Trials of lumbar spondylolisthesis are difficult to compare because of the heterogeneity in the populations studied. OBJECTIVE To define patterns of clinical presentation. METHODS This is a study of the prospective Quality Outcomes Database spondylolisthesis registry, including patients who underwent single-segment surgery for grade 1 degenerative lumbar spondylolisthesis. Twenty-four-month patient-reported outcomes (PROs) were collected. A k-means clustering analysis—an unsupervised machine learning algorithm—was used to identify clinical presentation phenotypes. RESULTS Overall, 608 patients were identified, of which 507 (83.4%) had 24-mo follow-up. Clustering revealed 2 distinct cohorts. Cluster 1 (high disease burden) was younger, had higher body mass index (BMI) and American Society of Anesthesiologist (ASA) grades, and globally worse baseline PROs. Cluster 2 (intermediate disease burden) was older and had lower BMI and ASA grades, and intermediate baseline PROs. Baseline radiographic parameters were similar ( P > .05). Both clusters improved clinically ( P < .001 all 24-mo PROs). In multivariable adjusted analyses, mean 24-mo Oswestry Disability Index (ODI), Numeric Rating Scale Back Pain (NRS-BP), Numeric Rating Scale Leg Pain, and EuroQol-5D (EQ-5D) were markedly worse for the high-disease-burden cluster (adjusted- P < .001). However, the high-disease-burden cluster demonstrated greater 24-mo improvements for ODI, NRS-BP, and EQ-5D (adjusted- P < .05) and a higher proportion reaching ODI minimal clinically important difference (MCID) (adjusted- P = .001). High-disease-burden cluster had lower satisfaction (adjusted- P = .02). CONCLUSION We define 2 distinct phenotypes—those with high vs intermediate disease burden—operated for lumbar spondylolisthesis. Those with high disease burden were less satisfied, had a lower quality of life, and more disability, more back pain, and more leg pain than those with intermediate disease burden, but had greater magnitudes of improvement in disability, back pain, quality of life, and more often reached ODI MCID.
Morbidity and Function Loss After Resection of Malignant Peripheral Nerve Sheath Tumors
Martin, Enrico , Pendleton, Courtney , Verhoef, Cornelis , Spinner, Robert J. , Coert, J. Henk , Verhoef, Cornelis

Mayo Clinic

Neurosurgery | September 8, 2021 | Volume: 90 | Issue: 3 | Pages: 354-364

10.1093/neuros/nyab342 | PMID 34528095 Get It

BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft tissue sarcomas. Their resection may lead to serious morbidity. Incidence of postoperative motor and sensory deficits is unknown, and reconstruction aimed at restoring such deficits is infrequently carried out. OBJECTIVE: To identify the incidence and risk factors of postoperative morbidity in MPNST as well as the use and outcomes of functional reconstructions in these patients. METHODS: Postoperative function and treatment of MPNSTs diagnosed from 1988 to 2019 in 10 cancer centers was obtained. Two models were constructed evaluating factors independently associated with postoperative motor (<M3) or critical sensory loss. Critical sensation was defined as partial or complete loss of hand, foot, or buttocks sensation. RESULTS: A total of 756 patients (33.4% neurofibromatosis type 1, NF1) were included. MPNSTs originated in 34.4% from a major nerve. Of 658 surgically treated patients, 27.2% had <M3 muscle power and 24.3% critical sensory loss. Amputations were carried out in 61 patients. Independent risk factors for motor and sensory loss included patients with NF1, symptomatic, deep-seated, extremity, or plexus tumors originating from major nerves (all P < .05). A total of 26 patients underwent functional reconstructions. The majority (64%) of these patients regained at least M3 muscle power and 33% M4 despite 86% receiving multimodal therapy. CONCLUSION: Resection of MPNSTs commonly results in motor and sensory deficits. Patients with NF1, symptomatic, deep-seated tumors, arising from major nerves were associated with a higher risk for developing postoperative morbidity. Functional reconstructions are infrequently performed but can improve functional outcomes.
Commentary: Dr Dorothy Kenke Nash: The First Woman Neurosurgeon in the United States
Gassie, Kelly , Quiñones‐Hinojosa, Alfredo , Dagi, T. Forcht , Dagi, T Forcht

Mayo Clinic

Neurosurgery | September 8, 2021 | Volume: 89 | Issue: 6 | Pages: E318-E322

10.1093/neuros/nyab338 | PMID 34498701 Get It

The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids
Sexton, Michelle , Garcia, José M. , Jatoi, Aminah , Clark, Carey S. , Wallace, Mark S. , Garcia, Jose M

Mayo Clinic

JNCI Monographs | September 8, 2021 | Volume: 2021 | Issue: 58 | Pages: 86-98

10.1093/jncimonographs/lgab011 | PMID 34850897 Get It

Abstract Cannabis and cannabinoids are increasingly being accessed and used by patients with advanced cancer for various symptoms and general quality of life. Specific symptoms of pain, nausea and vomiting, loss of appetite and cachexia, anxiety, sleep disturbance, and medical trauma are among those that have prompted patients with cancer to use cannabis. This conference report from the National Cancer Institute’s “Cannabis, Cannabinoid and Cancer Research Symposium” on the topic of “Cancer Symptom/Treatment Side Effect Management” is an expert perspective of cannabis intervention for cancer and cancer treatment-related symptoms. The purpose of the symposium was to identify research gaps, describe the need for high-quality randomized prospective studies of medical cannabis for palliative care in patients with cancer, and evaluate the impact of medical cannabis on cancer survivors’ quality of life. Further, education of clinicians and affiliated health-care providers in guiding cancer patients in using cannabis for cancer care would benefit patients. Together, these steps will further aid in refining the use of cannabis and cannabinoids for symptom palliation and improve safety and efficacy for patients.
Management of severe traumatic brain injury in regions with limited resources
Rubiano, Andrés M. , Griswold, Dylan , Jibaja, Manuel, Rabinstein, Alejandro A. , Godoy, Daniel Agustín , Griswold, Dylan P , Rabinstein, Alejandro A

Mayo Clinic

Brain Injury | September 8, 2021 | Volume: 35 | Issue: 11 | Pages: 1317-1325

10.1080/02699052.2021.1972149 | PMID 34493135 Get It

Monogenic Epilepsies
Guerrini, Renzo , Balestrini, Simona , Walker, Matthew C. , Balestrini, Simona , Guerrini, Renzo , Walker, Matthew C , Wirrell, Elaine

Mayo Clinic

Neurology | September 7, 2021 | Volume: 97 | Issue: 17 | Pages: 817-831

10.1212/wnl.0000000000012744 | PMID 34493617 Get It

Effect Size of Rituximab on Pulmonary Function in the Treatment of Connective-Tissue Disease-Related Interstitial Lung Disease: A Systematic Review and Meta-Analysis
Zhao, Yuanchen , Gao, Yang , Cheungpasitporn, Wisit , Moua, Teng , Cheungpasitporn, Wisit , Petnak, Tananchai , Thongprayoon, Charat , Zhang, Xing Y.

Mayo Clinic

No container title available | September 7, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-837872/v1 Get It

Abstract BACKGROUND: Rituximab (RTX) has been previously reported as directed treatment in patients with connective-tissue disease-related interstitial lung diseases (CTD-ILD). A systematic assessment of treatment effect size on pulmonary function outcomes and related adverse effects in patients with CTD-ILD has not been previously reported.METHODS: We performed a systematic review and meta-analysis of published reports from PubMed, Embase, and Cochrane Libraries. Randomized and non-randomized controlled trials, case-control, cohort, and case series (with five or more cases) containing individual pulmonary function data and adverse effects were included. Study endpoints were pre and post treatment change in percent predicted forced vital capacity (FVC %) and diffusion capacity for carbon monoxide (DLCO%), along with reported drug-related adverse events. RESULTS: Twenty studies totaling 411 patients were identified with 14 included in the meta-analysis of pulmonary function and six in the descriptive review. Random effects meta-analysis of pre and post-treatment pulmonary function findings demonstrated increases in FVC% (n =296) (mean difference (MD) 4.57%, [95% CI 2.63-6.51]) and DLCO% (n = 246) (MD 5.0% [95% CI 2.71-7.29]) after RTX treatment. RTX treatment-related adverse effects were reported in 13.6% of the pooled cohort. CONCLUSIONS: A systematic assessment of post-treatment effect size suggests a potential role for RTX in stabilizing or improving lung function in patients with CTD-ILD, with a modest but not insignificant adverse effect profile.